C12N 2770/20063
By chemical treatment
Official title: by chemical treatment
C12N2770/20063 (By chemical treatment) appears on 14 US grants and 27 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 27
- Assignees
- 17
- Inventors
- 74
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 3 |
| 2016 | 0 | 1 |
| 2017 | 1 | 3 |
| 2018 | 1 | 2 |
| 2019 | 2 | 1 |
| 2020 | 1 | 0 |
| 2021 | 2 | 1 |
| 2022 | 1 | 6 |
| 2023 | 1 | 2 |
| 2024 | 1 | 4 |
| 2025 | 2 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Viral vaccines and methods of forming the same7 Oct 2025US 12,435,317 B2NDSU Research Foundation
- Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus6 May 2025US 12,290,557 B2Zoetis Services LLC
- HCoV immunogenic booster composition for improving immunityagainst SARS-COV-2 infection24 Dec 2024US 12,171,826 B2
- Prevention of viral transmission by naked genetic material9 May 2023US 11,643,641 B2
- Viral vaccines and methods of forming the same29 Mar 2022US 11,286,464 B2NDSU Research Foundation
- Method for manufacturing inactivated sars-cov-2 vaccine, inactivated sars-cov-2 vaccine, method for purifying sars-cov-2 or inactivated sars-cov-2, and sars-cov-2 antigen composition or inactivated sars-cov-2 antigen composition12 Feb 2026US 2026/0041762 A1KM Biologics Co., Ltd.
- A vaccine for coronavirus and influenza virus, and method for preparation thereof5 Dec 2024US 2024/0398930 A1Bharat Biotech International Limited
- Inactivated sars-cov-2 virus vaccine5 Sep 2024US 2024/0293531 A1Valneva Austria GmbH
- Novel Vaccine Compositions for Porcine Epidemic Diarrhea Virus and Porcine Deltacoronavirus11 Jul 2024US 2024/0226270 A1Zoetis Services LLC
- Coronavirus vaccine and method for preparation thereof15 Feb 2024US 2024/0050557 A1Bharat Biotech International Limited
Most cited
By later US patents
- Porcine epidemic diarrhea virus vaccine4US 9,950,061 B2Boehringer Ingelheim Vetmedica GmbH · 2018
- Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus2US 10,251,950 B2Zoetis Services LLC · 2019
- Cationic polyamines for treatment of viruses2US 10,485,824 B2Agency for Science, Technology and Research · 2019
- Cationic polyamines for treatment of viruses2US 9,682,100 B2Agency for Science, Technology and Research · 2017
- Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus1US 10,953,088 B2Zoetis Services LLC · 2021